The study found that while the drug may reduce bone strength in the young, it could protect against osteoporosis, a weakening of the bones, in later life.
The results were uncovered by a team at the University of Edinburgh who compared the drug’s effects on mice.
Osteoporosis affects up to 30% of women and about 12% of men at some point in their lives.
